fashion -WSS

fashion

author：comprehensive 2025-09-27 22:49:43 - browse：9486

Julia Rendleman/Getty Images for Eventive Marketing

Health insurer Cigna is paying more than $172 million to settle allegations that it committed fraud by knowingly submitting inaccurate diagnoses of its Medicare Advantage members, the company and Department of Justice announced Saturday.

The settlement stems from a wide-ranging government investigation into the coding practices of Medicare Advantage insurers, as well as a specific whistleblower lawsuit against Cigna that the DOJ joined last year.

That lawsuit alleged Cigna’s home visit program “regularly generated false and invalid diagnosis codes for certain serious, complex conditions that cannot be reliably diagnosed in a home setting and without extensive diagnostic testing or imaging,” the DOJ said.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： 6 solutions to address cancer drug shortages and others

WSS

Pig kidney works a record two months in donated body

With Roe v Wade overturned, abortion providers work to adapt

CDC picks Alphabet's Verily for wasterwater surveillance contract

Experts study whether long Covid risk adds up with each reinfection

CRISPR base editing slashes cholesterol levels in monkeys

Food makers tried to stack nutrition panel with preferred experts

entertainment

fashion

focus

Heart attack and stroke risk calculators need revising

Lawsuit highlights wrinkle for disputes over surprise medical bills

Guidelines to prevent youth baseball injuries need more muscle

2023 Nobel Prize in Medicine goes to Karikó and Weissman

How one medical school became remarkably diverse

A common UTI test for kids haunts adults as a traumatic 'nightmare'

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Diverse clinical trials: Why aren’t we there yet?

Continuity nursing helped my family in our darkest PICU moments

New weight loss drugs vying to be the next Wegovy or Mounjaro

hotspot

Walmart eyes Medicare Advantage provider ChenMed

Diverse clinical trials: Why aren’t we there yet?

Stop Congress from blocking public access to science

FDA panel endorses Alnylam’s heart drug — after picking it apart

Pig kidney works a record two months in donated body

Medicare innovation center doesn’t save money, experts say

knowledge

knowledge

leisure time

leisure time